{
    "id": "clinical_knowledge-243",
    "question": "Which of the following is true of the assessment of power in the arms?",
    "options": {
        "A": "Grade 3/5 (MRC scale) represents movement of the arm only when gravity is eliminated",
        "B": "Flexion at the elbow is produced by the triceps muscle",
        "C": "The root value of shoulder abduction is C5",
        "D": "Grade 1/5 power represents no movement or muscle contraction"
    },
    "answer": "C",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to understand the concept of power in the context of medical assessment, particularly in relation to the muscle strength grading system. The Medical Research Council (MRC) grading system is used to assess muscle strength in adults. The system grades muscle strength from 0 to 5, with 0 being no movement or muscle contraction and 5 being normal muscle strength. The grading is based on the ability to perform specific actions such as flexion, extension, abduction, and adduction of the shoulder and elbow joints. The question asks about the assessment of power in the arms, which is related to the muscle strength grading system. We need to analyze the options provided and identify the correct statement about power in the arms.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "First_Aid_Step2_235",
            "title": "First_Aid_Step2",
            "content": "The confidence interval (CI) is a way of expressing statistical signif cance (p-value) that shows the size of the effect and the statistical power. CIs are interpreted as follows: If one is using a 95% CI, there is a 95% chance that the interval contains the true effect size, which is likely to be closest to the point estimate near the center of the interval. Example: You would like to estimate the percentage of women with a specifc disease. A 10% result from a sample of 3000 women would provide a 95% CI of 9%\u201311%, whereas a 10% f nding from a sample of 30 women would yield a CI of \u20131% of 21%. The frst case has more power because the sample size is larger, producing a narrow interval. In the latter case, you cannot state with 95% certainty that women in general even have the disease! If the CI includes the value corresponding to a relative risk of 1.0 (i.e., zero treatment difference), the results are not statistically signif cant. If the CI is wide, power is low."
        },
        {
            "id": "Surgery_Schwartz_14028",
            "title": "Surgery_Schwartz",
            "content": "the null hypothesis is rejected given that it is true. The error rate may also be referred to as the significance level, and often a value of 0.05, or 5%, is frequently used in the literature.Type II Error. A type II error is the failure to reject the null hypothesis when the null hypothesis is false. This error may also be referred to as a false negative. The type II error rate is denoted by the Greek letter \u03b2 (beta), and is related to the power of a study. Power can range from 0 to 1, and as power increases, there is decreasing probability of making a type II error. Power is related to three main factors: (a) the statistical significance criterion of the study, (b) the magnitude of the effect of interest, and (c) the sample size used to detect the effect. Power analysis can be used to calculate the minimum sample size required for a study so that one can be likely to detect an effect of a given size.P ValuesThe P value was an innovation most closely associated with Sir Ronald"
        },
        {
            "id": "First_Aid_Step2_234",
            "title": "First_Aid_Step2",
            "content": "Type I (\u03b1) error: Defned as the probability of saying that there is a difference in treatment effects between groups when in fact there is not (i.e., a false-conclusion). The p-value is an estimate of the probability that differences in treatment effects in a study could have happened by chance alone. Classically, differences associated with a p < 0.05 are statistically signif cant. Type II (\u03b2) error: Defned as the probability of saying that there is no difference in treatment effects (i.e., a falseconclusion) when in fact a difference exists. Power is the probability that a study will fnd a statistically signif cant difference when one is truly there. It relates directly to the number of subjects. Power (\u03b2) = 1 \u2013 type II error. The confidence interval (CI) is a way of expressing statistical signif cance (p-value) that shows the size of the effect and the statistical power. CIs are interpreted as follows:"
        },
        {
            "id": "Neurology_Adams_49",
            "title": "Neurology_Adams",
            "content": "Testing of Motor Function In the assessment of motor function, the most informative aspects are observations of the speed, power, muscle bulk, tone, and coordination. The maintenance of the supinated arms against gravity is a useful test; the weak arm, tiring first, soon begins to sag, or, in the case of a corticospinal lesion, to resume the more natural pronated position (\u201cpronator drift\u201d). An additional sign of subtle weakness of one side is the asymmetric \u201corbiting\u201d of one forearm around the other when the patient is asked to rotate the fists or index fingers around the other. The strength of the legs can be tested with the patient prone and the knees flexed and observing downward drift of the weakened leg. In the supine position at rest, weakness due to an upper motor neuron lesion causes external rotation of the hip. In testing the power of the legs, it should be kept in mind that the hip flexors and quadriceps of most adults are stronger than the arm of the examiner."
        },
        {
            "id": "Pediatrics_Nelson_3776",
            "title": "Pediatrics_Nelson",
            "content": "In infants, power is assessed by observation of spontaneous movements and movements against gravity. Arm and leg movements should be symmetrical, seen best when the infant is held supine with one hand supporting the buttocks and one supporting the shoulders. The limbs should easily lift up. Power is graded as follows: 5 Normal 4 Weak but able to provide resistance 3 Able to move against gravity but not against resistance 2 Unable to move against gravity"
        },
        {
            "id": "Surgery_Schwartz_14053",
            "title": "Surgery_Schwartz",
            "content": "for this phenomenon other than increasing the power of each individual study.Due to the combination of the aforementioned factors, the current framework of research means it is quite difficult to end up with a PPV >50%. Based on mathematical principles, even a well-constructed, adequately powered RCT with a pretest probability of 50% will arrive at a true conclusion only about 85% of the time.31 These findings limit the available literature upon which evidence-based medicine (EBM) relies and place a greater burden on practitioners when they are attempting to analyze and draw conclusions from what they find.Medical ReversalA related topic that directly impacts how EBM is carried out is that of medical reversal. This term was introduced by Vinay Prasad and Adam Cifu in 201150,51 to describe the process and pitfalls by which a previously established practice or drug falls out of favor because it is subsequently identified not to work. As such, the issue of medical reversal is impacted by"
        },
        {
            "id": "Surgery_Schwartz_14051",
            "title": "Surgery_Schwartz",
            "content": "that in modern research there is an intrinsic bias towards positive results in publication. Biases in study design, data collection, data analysis, or presentation of findings can lead to research findings when they do not truly exist. As bias increases, the positive predictive value (PPV) of a given finding being true decreases considerably. The overall effect of bias again depends on both the power and prestudy odds of a given study. In some fields, it may in fact be the case that research findings are simply a measure of the prevailing bias. Medical research operates in areas with low preand poststudy probability for true findings, meaning it may be quite common that observed effect sizes varying around the null hypothesis (what one would expect from chance alone) are simply measuring the prevailing bias of a given field.In addition to bias, the globalization of research means that at any given time it is almost a certainty that multiple research teams are investigating the same"
        },
        {
            "id": "First_Aid_Step1_262",
            "title": "First_Aid_Step1",
            "content": "Asymmetry with longer tail on right. Negative skew Typically, mean < median < mode. Mode Asymmetry with longer tail on left. Statistical hypotheses Outcomes of statistical hypothesis testing Correct result Stating that there is an effect or difference when Reality one exists (null hypothesis rejected in favor of HH alternative hypothesis). Stating that there is no effect or difference when none exists (null hypothesis not rejected). Blue shading = correct result. Confidence interval Range of values within which the true mean of the population is expected to fall, with a specified probability. CI for sample mean = x\u00af \u00b1 Z(SE) The 95% CI (corresponding to \u03b1 = .05) is often used. As sample size increases, CI narrows. For the 95% CI, Z = 1.96. For the 99% CI, Z = 2.58. If the 95% CI for a mean difference between 2 variables includes 0, then there is no significant difference and H0 is not rejected. If the 95% CI for odds ratio or relative risk includes 1, H0 is not rejected."
        },
        {
            "id": "First_Aid_Step1_263",
            "title": "First_Aid_Step1",
            "content": "If the 95% CI for odds ratio or relative risk includes 1, H0 is not rejected. If the CIs between 2 groups do not overlap \u008e statistically significant difference exists. If the CIs between 2 groups overlap \u008e usually no significant difference exists. Meta-analysis A method of statistical analysis that pools summary data (eg, means, RRs) from multiple studies for a more precise estimate of the size of an effect. Also estimates heterogeneity of effect sizes between studies. Improves power, strength of evidence, and generalizability of study findings. Limited by quality of individual studies and bias in study selection. Autonomy Obligation to respect patients as individuals (truth-telling, confidentiality), to create conditions necessary for autonomous choice (informed consent), and to honor their preference in accepting or not accepting medical care."
        },
        {
            "id": "First_Aid_Step2_229",
            "title": "First_Aid_Step2",
            "content": "A randomized controlled trial is an experimental, prospective study in which subjects are randomly assigned to a treatment or control group. Random assignment helps ensure that the two groups are truly comparable. The control group may be treated with a placebo or with the accepted standard of care. The study may be masked in one of two ways: single-masked, in which patients do not know which treatment group they are in, or double-masked, in which neither the patients nor their physicians know who is in which group. Double-masked studies are the gold standard for studying treatment effects. Advantages of randomized controlled trials are as follows: They involve minimal bias. They have the potential to demonstrate causal relationships. Disadvantages include the following: They are costly and time intensive. Informed consent may be diffcult to obtain. Some interventions (e.g., surgery) are not amenable to masking. Ethical standards cannot allow all variables to be controlled."
        },
        {
            "id": "First_Aid_Step1_252",
            "title": "First_Aid_Step1",
            "content": "Clinical trial Experimental study involving humans. Compares therapeutic benefits of \u22652 treatments, or of treatment and placebo. Study quality improves when study is randomized, controlled, and double-blinded (ie, neither patient nor doctor knows whether the patient is in the treatment or control group). Triple-blind refers to the additional blinding of the researchers analyzing the data. Four phases (\u201cDoes the drug SWIM?\u201d). Evaluation of Sensitivity and specificity are fixed properties Disease diagnostic tests of a test. PPV and NPV vary depending on disease prevalence in population being tested. SN-N-OUT = highly SeNsitive test, when Negative, rules OUT disease SP-P-IN = highly SPecific test, when Positive, rules IN disease PPV varies directly with pretest probability (baseline risk, such as prevalence of disease): NPV varies inversely with prevalence or pretest Quantifying risk Definitions and formulas are based on the classic 2 \u00d7 2 or contingency table."
        },
        {
            "id": "Immunology_Janeway_2246",
            "title": "Immunology_Janeway",
            "content": "Fig. 9.47 Cytotoxic T cells kill target cells bearing specific antigen while sparing neighboring uninfected cells. all the cells in a tissue are susceptible to killing by the cytotoxic proteins of armed effector Cd8 T cells, but only infected cells are killed. specific recognition by the T-cell receptor identifies which target cell to kill, and the polarized release of the cytotoxic granules (not shown) ensures that neighboring cells are spared. T cell recognizes infected cell Infected cell is programmed for death Neighboring uninfected cells are not killed Questions. 9.1 Multiple Choice: Which of the following statements is true? A. development of the arterial and venous system is regulated by the homeobox transcription factor prox1. B. arteries deliver lymphotoxin to the non-hematopoietic stromal LTi cell to induce lymph-node development. C. Lymphotoxin-\u03b13 signaling represses nF\u03baB to induce chemokines such as CXCL13."
        },
        {
            "id": "First_Aid_Step2_228",
            "title": "First_Aid_Step2",
            "content": "Probability of event creasing over time as patients die or drop out (are censored) from the study. Odds = 1 \u2212 probability of Studies are typically used to judge the best treatment for a disease. Although the gold standard for such evaluation is a randomized, double-masked controlled trial, other types of studies may be used as well (e.g., an observational F IGU R E 2.4-3. Example of a Kaplan-Meier curve. study, in which the exposure in question is a therapeutic intervention). In descending order of quality, published studies regarding treatment options include meta-analyses, randomized controlled trials, and case series/case reports."
        },
        {
            "id": "First_Aid_Step1_260",
            "title": "First_Aid_Step1",
            "content": "Crossover studies (subjects act as their own controls) Matching (patients with similar characteristics in both treatment and control groups) Lead-time bias Early detection is confused Early detection makes it seem Measure \u201cback-end\u201d survival with \u008f survival like survival has increased, (adjust survival according to but the disease\u2019s natural the severity of disease at the history has not changed time of diagnosis) Length-time bias Screening test detects diseases A slowly progressive cancer A randomized controlled trial with long latency period, is more likely detected by a assigning subjects to the while those with shorter screening test than a rapidly screening program or to no latency period become progressive cancer screening symptomatic earlier Mode = most common value. Least affected by outliers. Measures of Standard deviation = how much variability \u03c3 = SD; n = sample size. dispersion exists in a set of values, around the mean of Variance = (SD)2. these values. SE = \u03c3/\u221an."
        },
        {
            "id": "Surgery_Schwartz_14037",
            "title": "Surgery_Schwartz",
            "content": "controlled trials or came to conclusions that were different than the numerous studies that were published prior to 2004.38-40 Internal ConsistencyIn 2005, the GRADE working group published a pilot study of the system which found varied levels of agreement on the qual-ity of evidence for the outcomes in question among 17 asses-sors (kappa values [Box: The Kappa Coefficient] for agreement beyond chance ranged from 0 to 0.82; mean k = 0.27; k <0 for four judgements). The authors concluded that \u201cjudgements about evidence and recommendations are complex\u201d and stated that with discussion they could resolve most disagreements.41 No assessment of reliability or proof of usefulness has been presented regarding the GRADE system since these findings.42System IssuesThe GRADE group considers the \u201cstrength\u201d of their recom-mendations to reflect \u201cthe degree of confidence that the desir-able effects of adherence to a recommendation outweigh the The Kappa CoefficientThe Kappa coefficient is a statistic"
        },
        {
            "id": "Surgery_Schwartz_14041",
            "title": "Surgery_Schwartz",
            "content": "is a critical and defining feature of this new grading system.\u201d42 However, such a system allows for \u201chigh quality\u201d evidence for small effects while \u201clow quality\u201d evidence with a strong recommendation is highly implausible except for certain obvious observations.Finally, the touted advantage of the leveling process in determining the quality of evidence requires significant indi-vidual adjudication. A given study design begins at a level of quality and can be upgraded or downgraded based on several judgments regarding adequacy of blinding, follow-up, consis-tency, generalizability, and effect size. Graders are supposed to balance the level of quality using these factors, yet each is fun-damentally different and cannot be simply added or subtracted, and it is therefore up to individual judgment as to how to weigh each factor.ValidityThe GRADE system is well described in a series of publica-tions; however, none of the publications provide validation, data, or proof of the usefulness of"
        },
        {
            "id": "First_Aid_Step2_232",
            "title": "First_Aid_Step2",
            "content": "Lead-time bias: Results from earlier detection of disease, giving an appearance of prolonged survival when in fact the natural course is not altered. Example: A new and widely used screening test that detects cancer f ve Randomization minimizes bias and confounding; double-blinded studies prevent observation bias. Studies that are masked and randomized are better protected from the effects of bias, whereas observational studies are particularly susceptible to bias. Confounding variables reduce the internal validity of a study. years earlier may give the impression that patients are living longer with the disease."
        },
        {
            "id": "Surgery_Schwartz_14031",
            "title": "Surgery_Schwartz",
            "content": "categorizes statistical conclusions in a binary format. Should a P value of 0.049 be significant but a 0.051 not be significant? Furthermore, P values provide no insight into the effect size being measured. Simply, an intervention may be statistically significant but lack any clinical significance. Purely utilizing a P value to determine the value of research findings without assessing the effect size, confidence interval, and power of the study can be misleading.Despite these flaws identified in P values, the frequency of their appearance in modern literature has continued to increase.34 Each reader should be carefully skeptical of P values and await replication with similar significance for confirmation. Fisher did not anticipate or endorse the use of the modern P <0.05 criteria. Rather, he envisioned that experiments would be repeated until the investigator was sure that he or she had learned how to use the experimental intervention to get a predictable result.Alternative to P"
        },
        {
            "id": "First_Aid_Step2_233",
            "title": "First_Aid_Step2",
            "content": "Confounding variables reduce the internal validity of a study. years earlier may give the impression that patients are living longer with the disease. \u25a0 Length bias: Occurs when screening tests detect a disproportionate number of slowly progressive diseases but miss rapidly progressive ones, leading to overestimation of the beneft of the screen. Example: A better prognosis for patients with cancer is celebrated after implementation of a new screening program. However, this test disproportionally detects slow-growing tumors, which generally tend to be less aggressive. Even with bias reduction, unsystematic random error is unavoidable owing to chance variation in studied data. Types of errors are as follows: Type I (\u03b1) error: Defned as the probability of saying that there is a difference in treatment effects between groups when in fact there is not (i.e., a false-conclusion)."
        },
        {
            "id": "Gynecology_Novak_294",
            "title": "Gynecology_Novak",
            "content": "Beta Error and Power Type II (or beta) error re\ufb02ects the probability of failing to reject the null hypothesis when in reality it is incorrect (i.e., there truly was a treatment effect or a difference between the observed groups). In clinical trials it is important for the investigator to address the beta error, even in the design stage of the study. Study planners should calculate the power (or 1\u2013the beta error) that their study would have to detect an association, given assumptions made about the differences expected between treatments, and design the study size accordingly. Be aware that small clinical trials cited as evidence for \u201cno effect of therapy,\u201d may not have an adequate sample size to address the study question; in essence, the study is not powered to detect the difference."
        },
        {
            "id": "Neurology_Adams_11156",
            "title": "Neurology_Adams",
            "content": "Ascertaining the extent and severity of muscle weakness requires a systematic examination of the main groups of muscles. The patient is asked to contract each group with as much force as possible, while the examiner opposes the movement and offers a graded resistance in accordance with the degree of residual power (isokinetic contraction). Alternatively, the patient is asked to produce a maximal contraction and the examiner estimates power by the force needed to overcome or \u201cbreak\u201d it (isometric contraction or maximum voluntary isometric contraction). If the weakness is unilateral, one has the advantage of being able to compare it with the strength on the normal side. If it is bilateral, the physician must refer to his concept of what constitutes normalcy based on experience in muscle testing. As mentioned, one can distinguish true weakness from unwillingness to cooperate, feigned or neurasthenic weakness, and inhibition of movement by pain."
        },
        {
            "id": "Surgery_Schwartz_14039",
            "title": "Surgery_Schwartz",
            "content": "working group published a pilot study of the system which found varied levels of agreement on the qual-ity of evidence for the outcomes in question among 17 asses-sors (kappa values [Box: The Kappa Coefficient] for agreement beyond chance ranged from 0 to 0.82; mean k = 0.27; k <0 for four judgements). The authors concluded that \u201cjudgements about evidence and recommendations are complex\u201d and stated that with discussion they could resolve most disagreements.41 No assessment of reliability or proof of usefulness has been presented regarding the GRADE system since these findings.42System IssuesThe GRADE group considers the \u201cstrength\u201d of their recom-mendations to reflect \u201cthe degree of confidence that the desir-able effects of adherence to a recommendation outweigh the The Kappa CoefficientThe Kappa coefficient is a statistic that measures inter-rater agreement for qualitative items. It is thought to be a more robust measure than simple percent agreement since \u03ba takes into account the"
        },
        {
            "id": "InternalMed_Harrison_278",
            "title": "InternalMed_Harrison",
            "content": "The Greek prefix meta signifies something at a later or higher stage of development. Meta-analysis is research that combines and summarizes the available evidence quantitatively. Although occasionally used to examine nonrandomized studies, meta-analysis is used most typically to summarize all randomized trials examining a particular therapy. Ideally, unpublished trials should be identified and included to avoid publication bias (i.e., missing \u201cnegative\u201d trials that may not be published). Furthermore, the best meta-analyses obtain and analyze individual patient-level data from all trials rather than working only the summary data in published reports of each trial. Nonetheless, not all published meta-analyses yield reliable evidence for a particular problem, so their methodology should be scrutinized carefully to ensure proper study design and analysis. The results of a well-done meta-analysis are likely to be most persuasive if they include at least several large-scale, properly"
        },
        {
            "id": "Surgery_Schwartz_14048",
            "title": "Surgery_Schwartz",
            "content": "high-powered, low-bias meta analyses are not perfect, they do approach a theoretical \u201cgold standard\u201d of research, and although increasing power is important in arriving at correct conclusions, even high-powered studies can have significant biases. Additionally, obtaining large-scale evidence may not be possible for many research questions.Brunicardi_Ch51_p2137-p2152.indd 214928/02/19 4:19 PM 2150SPECIFIC CONSIDERATIONSPART IICrisis of Reproducibility and Medical Reversal: Implications for EBM\u201cYou keep using that word. I do not think it means what you think it means.\u201d\u2014Inigo Montoya from The Princess BrideThis chapter started by noting that the landscape of scientific knowledge is constantly evolving and that this fact impacts how we use and evaluate evidence as well. This 11th edition of Schwartz\u2019s Principles of Surgery is being produced at a particularly volatile period in biomedical research as basic assumptions as to how scientific literature determines what constitutes"
        },
        {
            "id": "First_Aid_Step1_257",
            "title": "First_Aid_Step1",
            "content": "Accuracy (validity) The closeness of test results to the true values. Systematic error \u0090 accuracy in a test. The absence of systematic error or bias in a test. ROC curve demonstrates how well a diagnostic 1 test can distinguish between 2 groups (eg, disease vs healthy). Plots the true-positive rate (sensitivity) against the false-positive rate (1 \u2013 specificity). The better performing test will have a higher area under the curve (AUC), with the curve closer to the upper left corner. No predictive value (AUC = 0.5)TP rate (sensitivity) FP rate (1 \u2013 specifcity) 1 A ctual test (0.5 < AU C < 1 ) Selection bias Nonrandom sampling or treatment allocation of subjects such that study population is not representative of target population. Most commonly a sampling bias. Berkson bias\u2014cases and/ or controls selected from hospitals are less healthy and have different exposures than general population"
        },
        {
            "id": "First_Aid_Step2_215",
            "title": "First_Aid_Step2",
            "content": "One cannot determine causal relationships because information is obtained only at a single point in time. The risk or incidence of disease cannot be directly measured. Physicians often use tests to try to ascertain a diagnosis, but because no test is perfect, a given result may be falsely or (see Figure 2.4-1). When deciding whether to administer a test, one should thus consider both its sensitivity and its specif city. \u25a0Sensitivity is the probability that a patient with a disease will have a test result. A sensitive test will rarely miss people with the disease and is therefore good at ruling people out. Incidence is measured with a cohort study; prevalence is measured with a prevalence study. As the mortality of a disease decreases, the prevalence of that disease increases (e.g., HIV infection). Another name for a prevalence study is a cross-sectional study. F IGU R E 2.4-1. Sensitivity, specificity, PPV, and NPV."
        },
        {
            "id": "Neurology_Adams_11158",
            "title": "Neurology_Adams",
            "content": "Further gradations may be added, specified as 4+ for barely detectable weakness and 4for easily detected weakness, 3+ and 3-, and so on. The ocular, facial, lingual, pharyngeal, laryngeal, cervical, shoulder, upper arm, lower arm and hand, truncal, pelvic, thigh, and lower leg and foot muscles are examined sequentially. It is most convenient to compare power generated by the same muscle from each side. To fully and properly use tools such as the MRC scale and to detect mild weakness, muscles such as the neck flexors and extensors must be tested with the patient in the prone and supine positions. The anatomic significance of each of the actions tested, that is, what roots, nerves, and muscles are involved, can be determined by referring to Table 45-1. A practiced examiner can survey the strength of these muscle groups in 2 to 3 min."
        },
        {
            "id": "Immunology_Janeway_204",
            "title": "Immunology_Janeway",
            "content": "B. lymph node C. Spleen D. thymus E. Appendix 1.10 Matching: match the following region, structure, or subcompartments with the numbered organ they are present in: A. lymph node __ B. Spleen __ C. mucosa of the small intestine __ 1. 2. 3. 1.11 Multiple Choice: Which of the following events do not occur during inflammation? A. Cytokine secretion B. Chemokine secretion C. recruitment of innate immune cells D. Constriction of blood vessels 1.12 Fill-in-the-Blanks: ___________ t cells are able to kill infected cells, while ________ t cells activate other cells of the immune system. 1.13 True or False: Both t-cell and B-cell receptors undergo the process of affinity maturation in order to acquire progressively higher affinity for an antigen during an immune response. 1.14 True or False: each lymphocyte carries cell-surface receptors with multiple antigen specificity."
        },
        {
            "id": "Surgery_Schwartz_14040",
            "title": "Surgery_Schwartz",
            "content": "Kappa coefficient is a statistic that measures inter-rater agreement for qualitative items. It is thought to be a more robust measure than simple percent agreement since \u03ba takes into account the possibility of the agreement occurring by chance. In general, \u03ba values < 0 indicate no agreement, 0 to 0.2 slight agreement, 0.21 to 0.4 fair agreement, 0.41 to 0.60 moderate agreement, 0.61 to 0.80 substantial agreement, and 0.81 to 1 as almost perfect agreement.undesirable effects.\u201d43 However, at the same time, the GRADE system allows the strength of a given recommendation to exist independent of the quality of evidence that underpins that recom-mendation. The GRADE Working Group states that \u201cseparating the judgements regarding the quality of evidence from judge-ments about the strength of recommendations is a critical and defining feature of this new grading system.\u201d42 However, such a system allows for \u201chigh quality\u201d evidence for small effects while \u201clow quality\u201d evidence with a strong"
        },
        {
            "id": "Surgery_Schwartz_14030",
            "title": "Surgery_Schwartz",
            "content": "patient sample and may not be gen-eralizable to the overall population. The probability of a false positive report not actually having an association depends not Brunicardi_Ch51_p2137-p2152.indd 214728/02/19 4:19 PM 2148SPECIFIC CONSIDERATIONSPART IIonly on the associated P value, but also the prior probability that the association is real and the statistical power of the given study.31,32 The basis of this is due to perpetual undersampling of all possible relationships in a given scientific domain. This will inherently lead to type I errors with respect to all clinical pos-sibilities. Recently, statisticians have postulated that utilizing a P value of 0.05 will lead to wrong conclusions at least 30% of the time and may be even higher with underpowered studies.33The use of P values also categorizes statistical conclusions in a binary format. Should a P value of 0.049 be significant but a 0.051 not be significant? Furthermore, P values provide no insight into the effect size being"
        },
        {
            "id": "First_Aid_Step1_489",
            "title": "First_Aid_Step1",
            "content": "A ]), assessed by \u201cempty/full can\u201d test nerves)\u2014internally rotates and adducts arm Innervated primarily by C5-C6. MUSCULOSKELETAL, SKIN, AND CONNECTIVE TISSUE ` anatomy and physiology SECTION III 447 Axillary (C5-C6) Fractured surgical neck of humerus Flattened deltoid Anterior dislocation of humerus Loss of arm abduction at shoulder (> 15\u00b0) Loss of sensation over deltoid and lateral arm Musculocutaneous Upper trunk compression \u0090 biceps (C5-6) reflex (C5-C7) Weakness of forearm flexion and supination Loss of sensation over lateral forearm Radial (C5-T1) Compression of axilla, eg, due to crutches or Wrist drop: loss of elbow, wrist, and finger sleeping with arm over chair (\u201cSaturday night extension palsy\u201d) \u0090 grip strength (wrist extension necessary for Midshaft fracture of humerus maximal action of flexors) Repetitive pronation/supination of forearm, eg, Loss of sensation over posterior arm/forearm and due to screwdriver use (\u201cfinger drop\u201d) dorsal hand"
        },
        {
            "id": "InternalMed_Harrison_280",
            "title": "InternalMed_Harrison",
            "content": "Meta-analyses typically focus on summary measures of relative treatment benefit, such as odds ratios or relative risks. Clinicians also should examine what absolute risk reduction (ARR) can be expected from the therapy. A useful summary metric of absolute treatment benefit is the number needed to treat (NNT) to prevent one adverse outcome event (e.g., death, stroke). NNT is simply 1/ARR. For example, if a hypothetical therapy reduced mortality rates over a 5-year follow-up by 33% (the relative treatment benefit) from 12% (control arm) to 8% (treatment arm), the ARR would be 12% \u2013 8% = 4%, and the NNT would be 1/0.04, or 25. Thus, it would be necessary to treat 25 patients for 5 years to prevent 1 death. If the hypothetical treatment was applied to a lower-risk population, say, with a 6% 5-year mortality, the 33% relative treatment benefit would reduce absolute mortality by 2% (from 6% to 4%), and the NNT for the same therapy in this lower-risk group of patients would be 50. Although"
        }
    ],
    "scores": [
        0.0344447861295377,
        0.03199687610180282,
        0.031013160322243404,
        0.025030878493129537,
        0.02381403357727077,
        0.023232323232323233,
        0.020171288602185408,
        0.019142700128228614,
        0.01886960391633289,
        0.018329427519250083,
        0.017733835530445698,
        0.017323775388291517,
        0.01730769230769231,
        0.01711402033204125,
        0.01709901351845086,
        0.01672194582642344,
        0.016394544110730366,
        0.016390179163901793,
        0.016254277441431954,
        0.016167318919612497,
        0.015864128406121687,
        0.015749007936507936,
        0.015675990675990677,
        0.015455304928989139,
        0.015159345391903532,
        0.015141242937853107,
        0.014912280701754385,
        0.01470276008492569,
        0.014662447257383967,
        0.014495028780743067,
        0.013877207737594618,
        0.013432323405716248
    ],
    "execution_time": 40.45009994506836
}